Stephen Feider's most recent trade in Beta Bionics Inc. was a trade of 4,413 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Aug. 22, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Beta Bionics Inc. | Stephen Feider | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Aug 2025 | 4,413 | 99,695 | - | - | Employee Stock Option (right to buy) | |
| Beta Bionics Inc. | Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 17.01 per share. | 22 Aug 2025 | 4,413 | 45,503 | - | 17.0 | 75,083 | Common Stock |
| Beta Bionics Inc. | Stephen Feider | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.10 per share. | 22 Aug 2025 | 4,413 | 49,916 | - | 5.1 | 22,506 | Common Stock |
| Beta Bionics Inc. | Stephen Feider | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Aug 2025 | 5,587 | 104,108 | - | - | Employee Stock Option (right to buy) | |
| Beta Bionics Inc. | Stephen Feider | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.10 per share. | 19 Aug 2025 | 5,587 | 51,090 | - | 5.1 | 28,494 | Common Stock |
| Beta Bionics Inc. | Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 17.03 per share. | 19 Aug 2025 | 5,587 | 45,503 | - | 17.0 | 95,172 | Common Stock |
| Beta Bionics Inc. | Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 18.15 per share. | 02 Jun 2025 | 951 | 45,639 | - | 18.1 | 17,260 | Common Stock |
| Beta Bionics Inc. | Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 17.03 per share. | 02 Jun 2025 | 410 | 46,590 | - | 17.0 | 6,981 | Common Stock |
| Beta Bionics Inc. | Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 18.69 per share. | 02 Jun 2025 | 136 | 45,503 | - | 18.7 | 2,542 | Common Stock |
| Beta Bionics Inc. | Stephen Feider | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 71,000 | 71,000 | - | - | Employee Stock Option (right to buy) | |
| Beta Bionics Inc. | Stephen Feider | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 47,000 | 47,000 | - | 0 | Common Stock | |
| Beta Bionics Inc. | Stephen Feider | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 186,203 | 186,203 | - | - | Employee Stock Option (right to buy) | |
| Beta Bionics Inc. | Stephen Feider | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 166,542 | 166,542 | - | - | Employee Stock Option (right to buy) | |
| Beta Bionics Inc. | Stephen Feider | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 109,695 | 109,695 | - | - | Employee Stock Option (right to buy) | |
| Beta Bionics Inc. | Stephen Feider | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2025 | 186,203 | 186,203 | - | - | Employee Stock Option (right to buy) |